Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA 2025-12-19 04:13 1 min The company says the observations are procedural in nature. 👍 0 👎 0 Share this post: Telegram WhatsApp X Facebook Copy link Comments (0) No comments yet.
No comments yet.